← All trials
NCT05595538
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 6, 2020
- Primary completion
- Sep 29, 2020
- Completion date
- Oct 14, 2020
- First posted
- Oct 27, 2022
- Last posted
- Oct 27, 2022
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hospital Regional Dr. Rafael EstévezLead sponsor
- Complejo Hospitalario Dr. Arnulfo Arias MadridOverall official - principal investigator
- Complejo Hospitalario Dr. Arnulfo Arias MadridCollaborator
- Hospital Santo TomasCollaborator
- Sistema Nacional de Investigación (SNI) - PanamáCollaborator
- Sociedad Panameña de HematologíaCollaborator
- Complejo Hospitalario Dr. Arnulfo Arias MadridOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.